Shares of Innova Captab experienced a decline of 2.91% following the announcement of the resignation of its Chief Financial Officer, Gaurav Srivastava, effective from March 29, 2024, citing personal reasons.
With Srivastava’s departure, he ceases to be the key managerial personnel (KMP) of the company as of the same date. The company clarified that the resignation was due to personal reasons, with no other material factors involved, as stated by the company.
Innova Captab, an integrated pharmaceutical company based in India, operates across the pharmaceutical value chain, encompassing research and development, manufacturing, drug distribution, marketing, and exports. The company’s operations span three main businesses: CDMO (contract development and manufacturing organization) services and products, domestic branded generics, and international branded generics.
Have you read?
Countries with the Highest Rates of Lung Cancer.
Countries with the highest rates of Dementia.
Countries with the Highest Rate of Diabetes.
Countries With the Most Car Accidents.
Countries with the Highest Teenage Pregnancy Rates.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
